Published online Aug 28, 2014. doi: 10.4329/wjr.v6.i8.583
Revised: July 9, 2014
Accepted: July 17, 2014
Published online: August 28, 2014
Processing time: 243 Days and 11.5 Hours
In acute promyelocytic leukemia, differentiation therapy based on all-trans-retinoic acid can be complicated by the development of a differentiation syndrome (DS). DS is a life-threatening complication, characterized by respiratory distress, unexplained fever, weight gain, interstitial lung infiltrates, pleural or pericardial effusions, hypotension and acute renal failure. The diagnosis of DS is made on clinical grounds and has proven to be difficult, because none of the symptoms is pathognomonic for the syndrome without any definitive diagnostic criteria. As DS can have subtle signs and symptoms at presentation but progress rapidly, end-stage DS clinical picture resembles the acute respiratory distress syndrome with extremely poor prognosis; so it is of absolute importance to be conscious of these complications and initiate therapy as soon as it was suspected. The radiologic appearance resembles the typical features of cardiogenic pulmonary edema. Diagnosis of DS remains a great skill for radiologists and haematologist but it is of an utmost importance the cooperation in suspect DS, detect the early signs of DS, examine the patients’ behaviour and rapidly detect the complications.
Core tip: Aim of this review is to illustrate the spectrum of chest imaging findings which lead to suspect a diagnosis of differentiation syndrome, which arise in patients suffering of Acute Promyelocytic Leukemia after treatment with all-trans-retinoic acid or other differentiating drugs, in order to facilitate the differential diagnosis with other life-threatening pulmonary complications occurring in this subset of highly immunocompromised patients.